对过去二十年心脏病学撤稿研究的分析。

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-09 DOI:10.1080/14796678.2024.2370698
Akash Sharma, Vidusha Karavadi, Harshini Suresh, Sowntappan Balasubramanian, Priyali Singh, Parteek Walia, U Venkatesh
{"title":"对过去二十年心脏病学撤稿研究的分析。","authors":"Akash Sharma, Vidusha Karavadi, Harshini Suresh, Sowntappan Balasubramanian, Priyali Singh, Parteek Walia, U Venkatesh","doi":"10.1080/14796678.2024.2370698","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The aim of this study is to analyze retracted studies in cardiovascular field.<b>Methodology:</b> PubMed and Embase databases were used to identify retracted publications from 2002 to 2022. Various characteristics of articles were retrieved, and an analysis was performed using R software.<b>Results:</b> We finally included 979 articles. Authors from China have the highest number of retracted studies (35.5%), followed by the USA (22.1%), and Japan (4%). The most common causes of retraction are mistakes and honest errors (24.5%) and duplicate data (17.7%). From 2002 to 2022, there has been a significant increase in retracted studies and a decrease in the impact factor of journals, number of citations, and time to retraction.<b>Conclusion:</b> The trend of retracting publications in cardiology is increasing.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"471-477"},"PeriodicalIF":1.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485899/pdf/","citationCount":"0","resultStr":"{\"title\":\"An analysis of retracted studies in cardiology in the last two decades.\",\"authors\":\"Akash Sharma, Vidusha Karavadi, Harshini Suresh, Sowntappan Balasubramanian, Priyali Singh, Parteek Walia, U Venkatesh\",\"doi\":\"10.1080/14796678.2024.2370698\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> The aim of this study is to analyze retracted studies in cardiovascular field.<b>Methodology:</b> PubMed and Embase databases were used to identify retracted publications from 2002 to 2022. Various characteristics of articles were retrieved, and an analysis was performed using R software.<b>Results:</b> We finally included 979 articles. Authors from China have the highest number of retracted studies (35.5%), followed by the USA (22.1%), and Japan (4%). The most common causes of retraction are mistakes and honest errors (24.5%) and duplicate data (17.7%). From 2002 to 2022, there has been a significant increase in retracted studies and a decrease in the impact factor of journals, number of citations, and time to retraction.<b>Conclusion:</b> The trend of retracting publications in cardiology is increasing.</p>\",\"PeriodicalId\":12589,\"journal\":{\"name\":\"Future cardiology\",\"volume\":\" \",\"pages\":\"471-477\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485899/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/14796678.2024.2370698\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2024.2370698","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

研究背景本研究旨在分析心血管领域的撤稿研究。研究方法:使用 PubMed 和 Embase 数据库识别 2002 年至 2022 年期间被撤回的出版物。检索文章的各种特征,并使用 R 软件进行分析。结果我们最终收录了 979 篇文章。来自中国的作者被撤稿的研究数量最多(35.5%),其次是美国(22.1%)和日本(4%)。最常见的撤稿原因是错误和诚信错误(24.5%)以及重复数据(17.7%)。从2002年到2022年,被撤稿的研究显著增加,期刊的影响因子、引用次数和撤稿时间均有所下降。结论心脏病学的撤稿趋势正在加剧。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An analysis of retracted studies in cardiology in the last two decades.

Background: The aim of this study is to analyze retracted studies in cardiovascular field.Methodology: PubMed and Embase databases were used to identify retracted publications from 2002 to 2022. Various characteristics of articles were retrieved, and an analysis was performed using R software.Results: We finally included 979 articles. Authors from China have the highest number of retracted studies (35.5%), followed by the USA (22.1%), and Japan (4%). The most common causes of retraction are mistakes and honest errors (24.5%) and duplicate data (17.7%). From 2002 to 2022, there has been a significant increase in retracted studies and a decrease in the impact factor of journals, number of citations, and time to retraction.Conclusion: The trend of retracting publications in cardiology is increasing.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Future cardiology
Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.80
自引率
5.90%
发文量
87
期刊介绍: Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.
期刊最新文献
Primary congenital abdominal aortic aneurysm associated with renovascular hypertension in pediatric patient. Operation in the gray zone: is SAVR still useful in patients aged between 75 and 80 years? Current approach to atherosclerotic cardiovascular disease risk prediction. Robotic magnetic-guided catheter ablation: an emerging treatment for congenital heart disease. Electrocardiographic and biochemical predictors of left ventricular remodeling early after ST-segment elevation myocardial infarction.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1